{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:38:43Z","timestamp":1786358323544,"version":"build-2736575974"},"reference-count":34,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010854","name":"Jiangsu Health Commission","doi-asserted-by":"publisher","award":["Z2025063"],"award-info":[{"award-number":["Z2025063"]}],"id":[{"id":"10.13039\/501100010854","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Project of Yancheng","award":["YCBK2024008"],"award-info":[{"award-number":["YCBK2024008"]}]},{"name":"Yancheng Health Committee Key Project","award":["YK2025052"],"award-info":[{"award-number":["YK2025052"]}]},{"name":"Startup Fund for high-level Talents of the Jiangsu Medical College","award":["20253139"],"award-info":[{"award-number":["20253139"]}]},{"name":"Jiangsu Medical College Innovative Research Team for Science and Technology","award":["20254305"],"award-info":[{"award-number":["20254305"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>PARP1\/2 inhibitors have received FDA approval for pancreatic cancer harboring BRCA1\/2 mutations and homologous recombination (HR) deficiency; however, their limited indications restrict their broader clinical application. Previous studies have demonstrated that PARP7, a member of the PARP family, enhances tumor sensitivity to PARP1\/2 inhibition. However, the mechanisms underlying their synergistic effects in pancreatic cancer remain unclear. Herein, we found that combined inhibition of PARP1\/2 and PARP7 using Olaparib and XYL-1 significantly inhibited the proliferation of SW1990 and CFPAC cells compared with either single agent. Furthermore, XYL-1 and Olaparib cooperatively caused DNA damage and induced cell apoptosis in SW1990 cells. Consistently, combined treatment with XYL-1 and Olaparib significantly suppressed SW1990 tumor growth compared with single-agent treatment in mouse xenograft models, accompanied by elevated levels of phosphorylated H2AX in tumor tissues. Notably, bioinformatic analyses and mechanistic studies identified SCD1 and BRCA1 as key mediators of the synergistic antitumor effects of XYL-1 and Olaparib. More importantly, the combination of XYL-1 and Olaparib synergistically downregulated the expression of SCD1 and BRCA1, thereby impairing the HR-mediated DNA repair pathway. Collectively, these findings suggest that dual targeting of PARP7 and PARP1\/2 may represent a promising therapeutic strategy for BRCA-proficient pancreatic cancer.<\/jats:p>","DOI":"10.3390\/molecules31162781","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:23:50Z","timestamp":1786357430000},"page":"2781","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["XYL-1 and Olaparib Synergistically Inhibit the Growth of Pancreatic Cancer by Suppressing the SCD1\/BRCA1 Signaling Pathway"],"prefix":"10.3390","volume":"31","author":[{"given":"Ye","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Medicinal Chemistry, Jiangsu Medical College, Yancheng 224005, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Medicinal Chemistry, Jiangsu Medical College, Yancheng 224005, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Chinese Traditional Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyue","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Chinese Traditional Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Jiangsu Medical College, Yancheng 224005, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjun","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Medicinal Chemistry, Jiangsu Medical College, Yancheng 224005, China"},{"name":"Department of Preventive Medicine, Jiangsu Medical College, Yancheng 224005, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.3748\/wjg.v27.i27.4298","article-title":"Pancreatic cancer: A review of epidemiology, trend, and risk factors","volume":"27","author":"Hu","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"116492","DOI":"10.1016\/j.bcp.2024.116492","article-title":"Overcoming therapy resistance in pancreatic cancer: New insights and future directions","volume":"229","author":"Patthey","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"106040","DOI":"10.1016\/j.phrs.2021.106040","article-title":"FDI-6 and olaparib synergistically inhibit the growth of pancreatic cancer by repressing BUB1, BRCA1 and CDC25A signaling pathways","volume":"175","author":"Wu","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Li, N., Zheng, H., Huang, Y., Zheng, B., Cai, H., and Liu, M. (2021). Cost-Effectiveness Analysis of Olaparib Maintenance Treatment for Germline BRCA-Mutated Metastatic Pancreatic Cancer. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.632818"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"eaaz3221","DOI":"10.1126\/sciadv.aaz3221","article-title":"Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomas","volume":"6","author":"Wang","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1093\/nar\/gkv118","article-title":"Roles of Rad51 paralogs for promoting homologous recombination in Leishmania infantum","volume":"43","author":"Genois","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1080\/14756366.2022.2053524","article-title":"Design and synthesis of benzodiazepines as brain penetrating PARP-1 inhibitors","volume":"37","author":"Yu","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1002\/ijc.33498","article-title":"A Phase I dose-escalation study of two cycles carboplatin-olaparib followed by olaparib monotherapy in patients with advanced cancer","volume":"148","author":"Geenen","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41467-022-28389-3","article-title":"Single-cell tumor-immune microenvironment of BRCA1\/2 mutated high-grade serous ovarian cancer","volume":"13","author":"Launonen","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ben Khaled, N., Hammer, K., Ye, L., Alnatsha, A., Widholz, S.A., Piseddu, I., Sirtl, S., Schneider, J., Munker, S., and Mahajan, U.M. (2022). TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of BRCA2 Mutation Status. Cancers, 14.","DOI":"10.3390\/cancers14215240"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s40262-017-0587-4","article-title":"PARP inhibitors in the treatment of triple-negative breast cancer","volume":"57","author":"Geenen","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41571-018-0114-z","article-title":"State-of-the-art strategies for targeting the DNA damage response in cancer","volume":"16","author":"Tang","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s12276-021-00557-3","article-title":"Alternate therapeutic pathways for PARP inhibitors and potential mechanisms of resistance","volume":"53","author":"Kim","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/s41419-021-04434-9","article-title":"FDI-6 inhibits the expression and function of FOXM1 to sensitize BRCA-proficient triple-negative breast cancer cells to Olaparib by regulating cell cycle progression and DNA damage repair","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kamata, T., Yang, C.-S., Melhuish, T.A., Frierson, H.F., Wotton, D., and Paschal, B.M. (2021). PostPost-Transcriptional Regulation of PARP7 Protein Stability Is Controlled by Androgen Signaling. Cells, 10.","DOI":"10.3390\/cells10020363"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Rasmussen, M., Tan, S., Somisetty, V.S., Hutin, D., Olafsen, N.E., Moen, A., Anonsen, J.H., Grant, D.M., and Matthews, J. (2021). PARP7 and Mono-ADP-Ribosylation Negatively Regulate Estrogen Receptor \u03b1 Signaling in Human Breast Cancer Cells. Cells, 10.","DOI":"10.3390\/cells10030623"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"108939","DOI":"10.1016\/j.bioorg.2025.108939","article-title":"Discovery of Bicyclo[1.1.1] pentane-based Olaparib derivatives as novel PARP inhibitors: A dual-action strategy targeting DNA damage and immune activation","volume":"165","author":"Liu","year":"2025","journal-title":"Bioorg. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Spirtos, A.N., Aljardali, M.W., Challa, S., Koul, S., Lea, J.S., Kraus, W.L., and Camacho, C.V. (2024). RBN-2397, a PARP7 Inhibitor, Synergizes with Paclitaxel to Inhibit Proliferation and Migration of Ovarian Cancer Cells. bioRxiv.","DOI":"10.1101\/2024.08.20.608802"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41588-024-01971-9","article-title":"A multilineage screen identifies actionable synthetic lethal interactions in human cancers","volume":"57","author":"Fong","year":"2025","journal-title":"Nat. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e16235","DOI":"10.15252\/emmm.202216235","article-title":"Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance","volume":"15","author":"Wang","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Zhu, S., Xiang, X., Xu, X., Gao, S., Mai, K., and Ai, Q. (2019). TIR Domain-Containing Adaptor-Inducing Interferon-\u03b2 (TRIF) Participates in Antiviral Immune Responses and Hepatic Lipogenesis of Large Yellow Croaker (Larimichthys crocea). Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02506"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.stemcr.2019.02.012","article-title":"Stearoyl CoA Desaturase Is Essential for Regulation of Endoplasmic Reticulum Homeostasis and Tumor Growth in Glioblastoma Cancer Stem Cells","volume":"12","author":"Pinkham","year":"2019","journal-title":"Stem Cell Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1903387","article-title":"Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer","volume":"381","author":"Golan","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neo.2021.12.002","article-title":"Panobinostat enhances olaparib efficacy by modifying expression of homologous recombination repair and immune transcripts in ovarian cancer","volume":"24","author":"Wilson","year":"2021","journal-title":"Neoplasia"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1158\/0008-5472.CAN-21-0732","article-title":"Repurposing ceritinib induces DNA damage and enhances PARP inhibitor responses in high-grade serous ovarian carcinoma","volume":"82","author":"Kanakkanthara","year":"2021","journal-title":"Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrrev.2015.07.001","article-title":"Persistent \u03b3H2AX: A promising molecular marker of DNA damage and aging","volume":"766","author":"Siddiqui","year":"2015","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41698-022-00298-0","article-title":"Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers","volume":"6","author":"Alblihy","year":"2022","journal-title":"NPJ Precis. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1158\/1535-7163.MCT-17-0256","article-title":"Amplification of the Mutation-Carrying BRCA2 Allele Promotes RAD51 Loading and PARP Inhibitor Resistance in the Absence of Reversion Mutations","volume":"19","author":"Park","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.18632\/aging.103082","article-title":"Inhibition of stearoyl-coenzyme A desaturase 1 ameliorates hepatic steatosis by inducing AMPK-mediated lipophagy","volume":"12","author":"Zhou","year":"2020","journal-title":"Aging"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"125307","DOI":"10.1016\/j.ijbiomac.2023.125307","article-title":"Dynamic role of Scd1 gene during mouse oocyte growth and maturation","volume":"247","author":"Niu","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"117223","DOI":"10.1016\/j.celrep.2026.117223","article-title":"SCD1 and SCD5 Modulate PARP-Dependent DNA Repair via Fatty Acid Desaturation in Glioblastoma","volume":"45","author":"Mnatsakanyan","year":"2026","journal-title":"Cell Rep."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Xu, Y., Du, Y., Zheng, Q., Zhou, T., Ye, B., Wu, Y., Xu, Q., and Meng, X. (2022). Identification of Ferroptosis-Related Prognostic Signature and Subtypes Related to the Immune Microenvironment for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.895110"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.antiviral.2018.07.010","article-title":"The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo","volume":"157","author":"Todt","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/nar\/gkv1173","article-title":"Requirement for human Mps1\/TTK in oxidative DNA damage repair and cell survival through MDM2 phosphorylation","volume":"44","author":"Yu","year":"2016","journal-title":"Nucleic Acids Res."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/16\/2781\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:24:48Z","timestamp":1786357488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/16\/2781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":34,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["molecules31162781"],"URL":"https:\/\/doi.org\/10.3390\/molecules31162781","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]}}}